Cytokine Microdialysis for Real-Time Immune Monitoring in Glioblastoma Patients Undergoing Checkpoint Blockade

NCT03493932 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

21

Enrollment

NIH

Sponsor class

Conditions

Glioblastoma

Interventions

DRUG: Nivolumab
DRUG: BMS-986016

Sponsor

National Institute of Neurological Disorders and Stroke (NINDS)